Investor Overview
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs for weight management, cardiovascular disease, inflammation and other disorders.
Our internally discovered and developed drug, BELVIQ® (lorcaserin HCl) is approved by the US Food and Drug Administration. Following are links to certain additional information:
We have granted exclusive marketing and distribution rights to Eisai Inc. for most of North and South America, and to Ildong Pharmaceutical Co., Ltd., for South Korea. We plan to enter into additional collaborations to commercialize BELVIQ outside of these territories.
Stock Information
Ticker:
ARNA
Exchange:
NASDAQ
Price:
6.21
Change:
+ 0.05
Open:
6.18
Previous Close:
6.16
Day High:
6.24
Day Low:
6.02
52-week High:
9.25
52-week Low:
4.05
Delayed at least 20 minutes. Provided by eSignal.
Featured Report
Receive Email Alerts
Click here to sign up for email alertsRecent Releases 
View All »
View All »Events & Presentations View All »
There are no upcoming events available at this time.